2m 2m 2m 2m 2m 2m 2m
ADMA Biologics (ADMA)
NASDAQ
$10.90-$0.05 (-0.46%)
Price as of Oct 22, 2026 7:30 PM EDT- $2.5BMarket Cap
- -27.37%1-Year Change
- BiotechnologyIndustry
ADMA Biologics (ADMA)
$10.90-$0.05 (-0.46%)
ADMA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.95 | ||
Change | -$0.22 (-1.96%) | ||
Open | $11.01 | ||
High | $11.11 | ||
Low | $10.80 | ||
Previous Close | $11.01 | ||
Volume | 3,551,548 | ||
30-Day Average Volume | 2,962,339 | ||
1-Week Change | 6.48% | ||
1-Month Change | 15.83% | ||
1-Year Change | -27.37% | ||
3-Year Change | 248.42% | ||
5-Year Change | 809.92% | ||
Fundamentals | |||
Shares Outstanding | 224.0M | ||
Total Assets | $684.2M | ||
Market Cap | $2.5B | ||
Enterprise Value | $2.5B | ||
Period: QTR TTM FY | |||
Revenue | $124.4M | ||
Net Income | $37.8M | ||
Free Cash Flow | $27.3M | ||
EBIT | $50.2M | ||
EBITDA | $52.0M | ||
Net Working Capital | $452.4M | ||
EPS | $0.16 | ||
Enterprise Value/EBITDA | 49 | ||
Enterprise Value/Revenue | 20 | ||
P/B | 6 | ||
P/E | 69 | ||
PEG | -4 | ||
Price/Free Cash Flow | 90 | ||
Price/Operating Cash Flow | 83 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue